Furthermore, Novo Nordisk is preparing for the expiration of its key semaglutide patent in China in 2026, potentially opening the door to lower-cost generics in most important markets
Separately, tirzepatide is also the active ingredient in Zepbound , which is FDA-approved for chronic weight management in adults with obesity, or in certain adults with overweight plus a weight-related comorbidity, and for obstructive sleep apnea in adults with obesity
This is why healthcare providers typically recommend starting with a low dose and gradually increasing it over several weeksa process known as titrationto allow your body time to adapt and minimize adverse reactions
The following conditions must be met in order to obtain and maintain a Practising Health Practitioner account and have access to practitioner-only products and services, as well as any materials pertaining to them (such as technical manuals, product information, access to training seminars and any other associated material